Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Intercept Pharmaceuticals (United States)

InstitutionResearch output, impact & collaborations

Intercept Pharmaceuticals (United States) is a research organisation in New York, US. OpenAlex records 334 works and 69,505 citations for it.

334
Works
69,505
Citations
95
Avg h-index

How has Intercept Pharmaceuticals (United States)'s publication output changed over time?

ScholarIQpublication output · 2012–2020

Output grew0% over the shown period — from 1 works in 2012 to 1 in 2020.

1
1
1
201220182020

What are the most-cited papers on Intercept Pharmaceuticals (United States)?

ScholarIQmost cited works
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in <i>db/db</i> Mice
Eleni Beli, Yuanqing Yan, Leni Moldovan, Cristiano Pedrozo Vieira, Ruli Gao, Yaqian Duan, Ram Prasad, Ashay D. Bhatwadekar, Fletcher A. White, Steven D. Townsend, Luisa Chan, Caitlin N. Ryan, Daniel Morton, Emil G. Moldovan, Fang-I Chu, Gavin Y. Oudit, Hartmut Derendorf, Luciano Adorini, Xiaoxin X. Wang, Carmella Evans‐Molina, Raghavendra G. Mirmira, Michael E. Boulton, Mervin C. Yöder, Qiuhong Li, Moshe Levi, Julia V. Busik, Maria B. Grant
S129060628. 2018386 CitationsOPEN ACCESS
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial
Michael Wang, Luis Fayad, Nicolaus A. Wagner‐Bartak, Liang Zhang, Fredrick Hagemeister, Sattva S. Neelapu, Felipe Samaniego, Peter McLaughlin, Michelle A. Fanale, Anas Younes, Fernando Cabanillas, Nathan Fowler, Kate J. Newberry, Luhong Sun, Ken H. Young, Richard E. Champlin, Larry W. Kwak, Lei Feng, Maria Badillo, Maria Teresa Bejarano, Kimberly Hartig, Wendy Chen, Yi‐Ming Chen, Catriona Byrne, Neda Bell, Jerome B. Zeldis, Jorge Romaguera
The Lancet Oncology. 2012297 Citations
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma
Patrizia Mondello, Saber Tadros, Matt Teater, Lorena Fontán, Aaron Y. Chang, Neeraj Jain, Haopeng Yang, Shailbala Singh, Hsia‐Yuan Ying, Chi-Shuen Chu, Man Chun John, Eneda Toska, Stefan Alig, Matthew Durant, Elisa de Stanchina, Sreejoyee Ghosh, Anja Mottok, Loretta J. Nastoupil, Sattva S. Neelapu, Oliver Weigert, Giorgio Inghirami, José Baselga, Anas Younes, Cassian Yee, Ahmet Doǧan, David A. Scheinberg, Robert G. Roeder, Ari Melnick, Michael R. Green
Cancer Discovery. 2020160 CitationsOPEN ACCESS

How much of the research on Intercept Pharmaceuticals (United States) is open access?

ScholarIQopen access share
67%OPEN ACCESS
Gold
0%
Green
0%
Hybrid
0%
Bronze
67%
Closed
33%

Related on ScholarIQ

Liver Diseases and Immunity
Top Topic
Drug Transport and Resistance Mechanisms
Top Topic
Liver Disease Diagnosis and Treatment
Top Topic
Pediatric Hepatobiliary Diseases and Treatments
Top Topic
Gallbladder and Bile Duct Disorders
Top Topic
Liver Disease and Transplantation
Top Topic
470M+ articles · free account